Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 07, 2020, titled "Dr. Reddy's Laboratories announces the launch ofFulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-dose Syringe in the U.S. Market".
Press Release Sep 07 2020
Filed with NSE · · 2 pages · English
Release
Dr. Reddy's Laboratories Ltd. on 6ix
Earlier from Dr. Reddy's Laboratories
- Press Release Sep 03 2020
- Press Release Aug 27 2020
- Press Release Aug 19 2020
- Press Release Aug 11 2020
Later from Dr. Reddy's Laboratories
- Press Release Sep 09 2020
- Press Release Sep 16 2020
- Press Release Sep 17 2020
- Press Release Sep 25 2020
- Press Release Sep 26 2020
Follow Dr. Reddy's Laboratories into a list and get an email when it puts out news.
Follow Dr. Reddy's Laboratories